Hybrid Conferencee

International Conference on Molecular Pathology (IC-MP - 26)

5th - 6th December 2026 | Istanbul, Turkey
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Programme

Tentative Conference Agenda

Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.

Conference Format Hybrid Conference In-person and virtual participation
Programme 2 Days 5–6 December 2026
Academic Scope 11 Tracks Conference Session Tracks
Research Scope 20 Areas Call for Papers themes
SDG Alignment 4 SDGs SDGs 3, 4, 9 and 16
Tentative Agenda & Timings

Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.

Day 01

Opening, Keynote & Technical Sessions

5 DEC 2026 HYBRID
  1. 09:00 AM 09:30 AM

    Registration, Welcome Kit Collection & Virtual Check-in

    Participant arrival, credential verification and virtual lobby access.

    HYBRID
  2. 09:30 AM 09:45 AM

    Networking Tea & Digital Welcome

    Informal networking for on-site and virtual participants.

    HYBRID
  3. 09:45 AM 10:30 AM

    Welcome Address, Opening Plenary & Keynote Presentation I

    Opening of the conference and introduction to its research focus.

    PLENARY
  4. 10:30 AM 12:30 PM

    Concurrent Technical Session I

    3 TRACKS
    Track 01
    Advancements in Molecular Diagnostics
    34
    Track Overview

    This track will explore the latest innovations in molecular diagnostic techniques that enhance disease detection and management. Emphasis will be placed on the integration of genomic data into clinical practice.

    Track 02
    Genomic Approaches to Cancer Pathology
    39
    Track Overview

    This session focuses on the application of genomic technologies in understanding cancer pathology. Researchers will present findings on how gene expression profiles can inform treatment strategies.

    Track 03
    Biomarkers in Disease Mechanisms
    39
    Track Overview

    This track will delve into the identification and validation of biomarkers that elucidate disease mechanisms. Discussions will highlight their potential in predicting disease progression and therapeutic responses.

  5. 12:30 PM 01:30 PM

    Lunch & Networking Break

    Refreshment interval and networking opportunity.

    BREAK
  6. 01:30 PM 03:30 PM

    Concurrent Technical Session II

    3 TRACKS
    Track 04
    Translational Research in Molecular Pathology
    34
    Track Overview

    This session aims to bridge the gap between laboratory research and clinical application in molecular pathology. Presentations will focus on successful translational research projects that have led to improved patient outcomes.

    Track 05
    Proteomics and Its Role in Personalized Medicine
    39
    Track Overview

    This track will examine the role of proteomics in the development of personalized medicine approaches. Participants will discuss how protein expression profiles can guide tailored therapeutic interventions.

    Track 06
    Emerging Technologies in Genomics
    39
    Track Overview

    This session will highlight cutting-edge technologies in genomics that are transforming the field of molecular pathology. Topics will include next-generation sequencing and CRISPR-based applications.

  7. 03:30 PM 04:00 PM

    Interactive Q&A, Day 1 Summary & Group Photo

    Closing interaction and key takeaways from the first day.

    CLOSING
Day 02

Keynote, Technical Sessions & Awards

6 DEC 2026 HYBRID
  1. 09:00 AM 09:15 AM

    Participant Check-in & Day 2 Welcome

    On-site attendance confirmation and virtual lobby access.

    HYBRID
  2. 09:15 AM 10:00 AM

    Keynote Presentation II

    Expert address on the future of the conference research domain.

    PLENARY
  3. 10:00 AM 12:00 PM

    Concurrent Technical Session III

    3 TRACKS
    Track 07
    Molecular Mechanisms of Disease
    39
    Track Overview

    This track will focus on the molecular mechanisms underlying various diseases, emphasizing the role of genetic and epigenetic factors. Researchers will share insights into how these mechanisms can inform therapeutic strategies.

    Track 08
    Clinical Applications of Biomarkers
    34
    Track Overview

    This session will explore the clinical relevance of biomarkers in diagnosis, prognosis, and treatment of diseases. Case studies will illustrate the impact of biomarker discovery on patient management.

    Track 09
    Integrative Approaches in Cancer Genomics
    39
    Track Overview

    This track will discuss integrative approaches that combine genomic, transcriptomic, and proteomic data to provide a comprehensive understanding of cancer biology. Presentations will focus on multi-omics strategies in cancer research.

  4. 12:00 PM 01:00 PM

    Lunch & Networking Break

    Refreshment interval and professional networking.

    BREAK
  5. 01:00 PM 03:00 PM

    Concurrent Technical Session IV

    2 TRACKS
    Track 10
    Ethical Considerations in Molecular Pathology
    16
    Track Overview

    This session will address the ethical implications of advancements in molecular pathology, particularly concerning patient privacy and data sharing. Discussions will aim to establish guidelines for responsible research practices.

    Track 11
    Future Directions in Molecular Pathology Research
    34
    Track Overview

    This track will provide a platform for discussing future trends and challenges in molecular pathology research. Participants will explore innovative research directions that could shape the future of health and medicine.

  6. 03:00 PM 03:30 PM

    Publications, Best Paper & Best Presentation Awards

    Publication guidance and recognition of outstanding research contributions.

    AWARDS
  7. 03:30 PM 04:00 PM

    Valedictory Session, Closing Remarks & Group Photo

    Conference summary, acknowledgements and formal conclusion.

    CLOSING
Aligned SDGs
3 Good Health and Well-being 4 Quality Education 9 Industry, Innovation and Infrastructure 16 Peace, Justice and Strong Institutions

Be Part of IC-MP-26

Submit your research or complete your conference registration.